Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: J Surg Res. 2019 Feb 13;238:164–174. doi: 10.1016/j.jss.2019.01.038

Fig. 3 —

Fig. 3 —

N-3 polyunsaturated fatty acid (PUFA) supplementation (ProOmega) increases levels of monohydroxy intermediates (A) and specialized pro-resolving lipid mediators (B) generated from eicosapentaenoic acid (EPA). *Statistical significance as defined by a P value < 0.05.. HEPE = hydroxyeicosapentaenoic acid; LXA5 = lipoxin A5; RvE1, E2, E3 = resolvin E1, E2, E3. (Color version of figure is available online.